A trial published in this week's issue of the Lancet

The study, called the International Subarachnoid Aneurysm Trial, shows the technique, known as coiling, is more likely to result in survival without disability for one year, when compared to neurosurgical clipping, which involves a craniotomy and clipping of the aneurysm to prevent further bleeding

Takeda Pharmaceutical Co. announces Tuesday approval from the U.S. Food and Drug Administration for its new diabetes drug.

Actoplus Met is a single tablet that merges Takeda's two existing diabetes drugs, Actos and Metformin. Takeda Pharmaceuticals North America Inc. will sell the tablet in the United States starting in October

Takeda Pharmaceutical Co. announces on Tuesday that it has obtained consent from the U.S. Food and Drug Administration for its new diabetes drug, reports The Associated Press.

Actoplus Met is a single tablet that merges Takeda's two existing diabetes drugs, Actos and Metformin. Takeda Pharmaceuticals North America Inc. will sell the tablet in the United States starting in October

As a way to fight childhood obesity, schools should limit the availability of soft drinks, the American Beverage Association says on Tuesday.

ABA President and CEO Susan Neely is to formally announce the organization's policy recommendation Wednesday at the annual meeting of the National Conference of State Legislatures in Seattle

Despite the links to skin cancer, current studies show young adults are not vigilant about excess sun exposure.

The American Cancer Society estimates 1.3 million cases of skin cancer will be diagnosed in the United States this year